Please login or register to print this page.

The British Journal
of Cardiology

This website is intended for healthcare professionals only

2005, Volume 12, Issue 05, pages 321-404

CLINICAL ARTICLE
Br J Cardiol 2005;12:401-3

Peripheral arterial disease – CVD by any other name?

The National Service Framework for Coronary Heart Disease (CHD) stated that individuals at greatest risk of CHD should be identified. This category included those with...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:397-400

Statin prescribing: is the reality meeting the expectations of primary care?

Two surveys were carried out to look at statin prescribing in UK general practice. The first was a study of the Mediplus prescribing database in...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:394-5

Meig’s syndrome with massive pericardial effusion, bilateral pleural effusion and ascites

Meig’s syndrome is a condition in which an ovarian tumour (usually a fibroma) is associated with ascites and pleural effusion. It resolves after resection of...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:392-3

COX-2 inhibitors: managing comorbidities in primary care

The recent withdrawal of rofecoxib, a COX-2 inhibitor, has focussed attention on the use of COX-2 inhibitors and other non-steroidal anti-inflammatory drugs (NSAIDs) in patients...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:387-91

COX-2 inhibitors and the cardiovascular system: is there a class effect?

Selective inhibition of COX-2 preferentially inhibits the production of prostaglandins responsible for vasodilation and inhibition of platelet aggregation. This potentially creates a pro-thrombotic state. This...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:379-86

New approaches to the management of dyslipidaemia

Multiple randomised controlled trials have unequivocally shown that lowering low-density lipoprotein cholesterol (LDL-C) results in a predictable reduction of coronary events and it appears that...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:372-8

Problems of cardiac rehabilitation coordinators in the UK: are perceptions justified by facts?

The National Service Framework for Coronary Heart Disease recommended in 2000 that cardiac rehabilitation (CR) should be offered to 85% of patients recovering from myocardial...

Read More

NEWS
Br J Cardiol 2005;12:368-70

The effects of cardiac rehabilitation on heart rate variability in patients with coronary heart disease

Structured exercise, as a therapeutic intervention, is central to cardiac rehabilitation (CR). Following myocardial infarction (MI), cardiac autonomic activity becomes disordered, often resulting in loss...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:361-6

Cardiac rehabilitation: results of a national survey

The provision of cardiac rehabilitation (CR) services in the UK was surveyed in March 2003. Three hundred questionnaires were sent to Directors of Public Health...

Read More

EDITORIAL
Br J Cardiol 2005;12:336-8

ASCOT – hold on to your horses!

The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) reported the final results of its blood pressure lowering arm at the European Society of Cardiology (ESC) Annual meeting...

Read More

EDITORIAL
Br J Cardiol 2005;12:333-5

Current and future status of left ventricular assist devices in the UK

Heart failure affects over 750,000 people in the UK and 65,000 new cases are diagnosed every year. It carries a poor prognosis with a population-based...

Read More

Close

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

Find out more about our membership benefits

Close

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.

Find out more about our membership benefits